United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a ...

More than three years after launching a new corporate structure, Novartis is still making changes to its organization. | More than three years after launching a new corporate structure, Novartis is ...

While a recent head-to-head trial of the obesity med heavyweights Wegovy and Zepbound favored the latter drug from Eli Lilly on weight loss, Novo Nordisk has now countered that result with ...

German generics maker Stada has settled on a buyout by CapVest Partners, putting an end to its previously reported IPO ambitions. | After musing a fall IPO just last week, Stada is instead being ...